KRTAP6-2
gene geneOn this page
Also known as KAP6.2
Summary
KRTAP6-2 (keratin associated protein 6-2, HGNC:18932) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 6-2 (Q3LI66). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Enables identical protein binding activity. Predicted to be involved in keratinization. Predicted to be located in cytosol.
Source: NCBI Gene 337967 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 17 total
- MANE Select transcript:
NM_181604
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18932 |
| Approved symbol | KRTAP6-2 |
| Name | keratin associated protein 6-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP6.2 |
| Ensembl gene | ENSG00000186930 |
| Ensembl biotype | protein_coding |
| Entrez | 337967 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334897
RefSeq mRNA: 1 — MANE Select: NM_181604
NM_181604
CCDS: CCDS13600
Canonical transcript exons
ENST00000334897 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337941 | 30598590 | 30598902 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 91.66.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.66 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| monocyte | CL:0000576 | 27.54 | gold quality |
| leukocyte | CL:0000738 | 27.54 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 24.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 23.89 | gold quality |
| frontal cortex | UBERON:0001870 | 23.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 6-2 — Q3LI66 (reviewed: Q3LI66)
All UniProt accessions (1): Q3LI66
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 6 family.
RefSeq proteins (1): NP_853635* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR040313 | KAP6 | Family |
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI66-F1 | 42.03 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 21 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, chr21q22, GOBP_SKIN_DEVELOPMENT, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOBP_KERATINOCYTE_DIFFERENTIATION, GOCC_SUPRAMOLECULAR_POLYMER, GOBP_EPITHELIAL_CELL_DIFFERENTIATION, TATA_01, TTANTCA_UNKNOWN
GO Biological Process (1): keratinization (GO:0031424)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
118 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP6-2 | KRTAP6-3 | Q3LI67 | 800 |
| KRTAP6-2 | KRTAP22-1 | Q3MIV0 | 795 |
| KRTAP6-2 | KRTAP24-1 | Q3LI83 | 795 |
| KRTAP6-2 | KRTAP6-1 | Q3LI64 | 791 |
| KRTAP6-2 | SCYGR1 | A0A286YEY9 | 790 |
| KRTAP6-2 | KRTAP20-2 | Q3LI61 | 783 |
| KRTAP6-2 | KRTAP26-1 | Q6PEX3 | 774 |
| KRTAP6-2 | KRTAP7-1 | Q8IUC3 | 773 |
| KRTAP6-2 | KRTAP13-3 | Q3SY46 | 772 |
| KRTAP6-2 | KRTAP8-1 | Q8IUC2 | 765 |
| KRTAP6-2 | KRTAP20-1 | Q3LI63 | 764 |
| KRTAP6-2 | KRTAP15-1 | Q3LI76 | 720 |
| KRTAP6-2 | KRTAP11-1 | Q8IUC1 | 716 |
| KRTAP6-2 | KRTAP13-1 | Q8IUC0 | 700 |
| KRTAP6-2 | KRTAP1-4 | P0C5Y4 | 643 |
IntAct
648 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP6-2 | VAC14 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | TNIP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | DAZAP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | CAMK2B | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | ATN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | KRTAP12-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | CAMK2A | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP6-2 | TRIP13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ESR2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FRS3 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NAF1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CATSPER1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHN1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LASP1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CYSRT1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CELF5 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LRRC41 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HAPLN2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NR1D2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PITX1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LRFN4 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RHOXF2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TCF7L2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMN1 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (187): KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP6-2 (Two-hybrid)
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI64, Q3LI66, Q3LI67, Q925H3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 152 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 14 | 10.8× | 9e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 6 | 10.8× | 3e-03 |
| anterior/posterior pattern specification | 6 | 8.4× | 8e-03 |
| anatomical structure morphogenesis | 7 | 7.5× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
71 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30598807:AGG:A | donor_gain | 0.8200 |
| 21:30598830:ATAG:A | donor_gain | 0.8200 |
| 21:30598791:T:TA | donor_gain | 0.8000 |
| 21:30598854:T:TA | donor_gain | 0.8000 |
| 21:30598822:CA:C | donor_gain | 0.7900 |
| 21:30598802:AG:A | donor_gain | 0.7500 |
| 21:30598823:A:AC | donor_gain | 0.7500 |
| 21:30598863:G:C | donor_gain | 0.7400 |
| 21:30598796:AG:A | donor_gain | 0.7100 |
| 21:30598818:T:C | donor_gain | 0.6900 |
| 21:30598832:AG:A | donor_gain | 0.6900 |
| 21:30598833:G:C | donor_gain | 0.6800 |
| 21:30598817:AT:A | donor_gain | 0.6400 |
| 21:30598745:AG:A | donor_gain | 0.6300 |
| 21:30598803:G:C | donor_gain | 0.6300 |
| 21:30598750:TG:T | donor_gain | 0.6100 |
| 21:30598746:G:C | donor_gain | 0.6000 |
| 21:30598828:C:CT | donor_gain | 0.5800 |
| 21:30598873:A:C | donor_gain | 0.5800 |
| 21:30598751:G:T | donor_gain | 0.5700 |
| 21:30598797:G:C | donor_gain | 0.5700 |
| 21:30598724:C:CT | acceptor_gain | 0.5600 |
| 21:30598683:T:TA | donor_gain | 0.5300 |
| 21:30598749:A:AC | donor_gain | 0.5100 |
| 21:30598850:AGTTT:A | donor_gain | 0.5000 |
| 21:30598874:T:TA | donor_gain | 0.5000 |
| 21:30598674:C:CA | donor_gain | 0.4900 |
| 21:30598792:C:A | donor_gain | 0.4900 |
| 21:30598830:ATAGC:A | donor_gain | 0.4900 |
| 21:30598825:C:T | donor_gain | 0.4800 |
AlphaMissense
388 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000111536 (21:30598958 A>G), RS1000270364 (21:30599228 A>C,G), RS1001937248 (21:30600540 C>T), RS1002154218 (21:30599353 T>C), RS1005241273 (21:30598678 C>A,T), RS1005506079 (21:30598441 G>A,C), RS1005735454 (21:30600017 A>G), RS1006098587 (21:30598281 C>T), RS1006181093 (21:30599722 A>G), RS1006775426 (21:30600893 A>G), RS1006916663 (21:30599979 C>T), RS1008849905 (21:30600846 C>G), RS1009351478 (21:30599064 G>A), RS1009690309 (21:30599429 A>T), RS1012097545 (21:30598920 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.